PBAC Public Summary Documents (first time rejections and deferrals) - March 2019 meeting

19 July 2019 - The Public Summary Documents (first time rejections and deferrals) from the March 2019 PBAC meeting are now ...

Read more →

Drug Utilisation Sub-Committee outcome statement

17 July 2019 - The outcome statement from the June 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Drug Utilisation Sub-Committee utilisation analysis public release documents

12 July 2019 - The utilisation analysis public release documents from the February 2019 Drug Utilisation Sub-Committee Meeting are now available. ...

Read more →

PBAC Public Summary Documents - March 2019 meeting

5 July 2019 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2019 PBAC ...

Read more →

Prices of Canadian generic medicines below international average

29 May 2019 - PMRPB: Canadian price declines steepest of all OECD countries. ...

Read more →

Asthma Stakeholder Meeting December 2018 – outcome statement

22 May 2019 - The outcome statement for the severe asthma stakeholder meeting held on 14 December 2018 is now available. ...

Read more →

PD-L(1) checkpoint inhibitor stakeholder meeting outcome statement

12 April 2019 - The outcome statement for the PD-(L)1 checkpoint inhibitor stakeholder meeting held on 8 February 2019 , ...

Read more →

Institute for Clinical and Economic Review posts draft scoping document for the assessment of treatments for rheumatoid arthritis

11 April 2019 - Document open to public comment until 1 May 2019. ...

Read more →

Institute for Clinical and Economic Review releases draft evidence report on treatments for peanut allergy

9 April 2019 - Public comment period now open until 8 May 2019; requests to make oral comment during public ...

Read more →

PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals)

15 March 2019 - The Public Summary Documents (first time rejections and deferrals) from the November 2018 PBAC meeting are now ...

Read more →

Institute for Clinical and Economic Review publishes white paper on alternative models for pharmaceutical rebates

12 March 2019 - Paper explores how reforming or eliminating rebates may affect drug pricing, patient access, and incentives for future ...

Read more →

Identifying the need for good practices in health technology assessment-summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

26 January 2019 - The systematic use of evidence to inform healthcare decisions, particularly health technology assessment, has gained increased recognition.  ...

Read more →

FDA is urged to mandate disclosure of clinical trial summaries as pilot program stalls

16 January 2019 - One year after the FDA launched a voluntary pilot program to release clinical study reports, which ...

Read more →

PBS Expenditure and Prescriptions Report 2017-18

11 January 2019 - The PBS Expenditure and Prescriptions Report 2017-18 is now available. ...

Read more →

CMS Office of the Actuary releases 2017 national health expenditures

6 December 2018 - Overall national health spending grew at a rate of 3.9% in 2017, almost 1.0 percentage point ...

Read more →